Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor vs Clopidogrel in COPD Patients Undergoing PCI for Stable CAD
NCT02519608Phase 2Completed
- Sponsor
- Azienda Ospedaliero-Universitaria di Ferrara
- Start
- Sep 2015
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ticagrelor in coronary artery disease (CAD), sponsored by Azienda Ospedaliero-Universitaria di Ferrara. Started Sep 2015; status: completed.
02
Drugs
ticagrelor
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT02519608.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02519608.